drugset / Trial / NCT01144494

Aqueous Humor Dynamics and Brimonidine

NCT01144494

Phase 0 Completed 35 enrolled University of Nebraska
RandomizedCrossoverDouble-blindTreatment

Summary

This single-center, investigator-masked, crossover study is designed to investigate the circadian rhythms of aqueous humor dynamics in human subjects with ocular hypertension (OHT) before and after intervention with a commonly used ocular hypotensive medication, brimonidine for six weeks.

Timeline

Start
2010-08-01
Primary completion
2011-10-01
Completion
2011-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Brimonidine Small molecule 0.2 % Topical

Indications